Dr. Hans Arwidsson holds a M.Sc. and a Ph.D. in pharmaceutical sciences from Uppsala University as well as an Executive MBA from Stockholm School of Economics. After more than three decades of broad cross-functional executive experience from the pharmaceutical industry he is now CEO of Eurocine Vaccines – a vaccine development company.

https://www.eurocine-vaccines.com/the-company/

Presentation Title: Build a fruitful relationship in BioTech – A case of how to create a successful outsourcing partnership between a vaccine developer and a CDMO, Eurocine Vaccines,and Biovian.

Abstract: The popularity of outsourcing within the Life Science-industry is increasing year by year. Finding, selecting, evaluating, and initiating a CDMO partnership may be challenging. In this presentation Eurocine Vaccines and Biovian share their insightful experience, working on a novel vaccine candidate against Chlamydia trachomatis.
While Eurocine Vaccines describes their process and checklist in selecting a partner, Biovian shares their point of view on what elements are important in building a fruitful relationship.

View company profile